EUVIMEDEUVIMED entdecken
Multizentrische Studie

Identification of phenotypes in heart failure with preserved ejection fraction among 8161 patients from 3 Spanish cohorts

Òscar Miró, Olivier Peyrony, Joan Carles Trullàs, Aitor Alquézar-Arbé, Julio Núñez, Pedro López-Ayala, Javier Jacob, Héctor Bueno, Manuel Montero-Pérez-Barquero, José Carlos Arévalo-Lorido, Rafael de la Espriella, Gema Miñana und 2 weitere

Revista Española de Cardiología (English Edition) · 2025

DOI: 10.1016/j.rec.2025.02.021 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Òscar Miró und 13 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Urgencias, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, Sp…. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Registries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Novartis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: To identify phenotypes in heart failure with preserved ejection fraction (HFpEF), compare mortality, and investigate whether treatments have different effects according to phenotype. METHODS: We performed a secondary analysis of 8161 patients with HFpEF included in Spanish cardiology (INCLIVA), internal medicine (RICA), and emergency (EAHFE) registries. Phenotypic clusters based on 16 baseline characteristics were identified using latent class analysis. We analyzed crude and treatment-adjusted 1-year survival, the associations between each treatment and mortality, and their interactions with phenotype. RESULTS: We identified 4 distinct clusters. One-year mortality was 18.7%. Cluster 4 (younger women with a valvular heart disease phenotype) had the lowest mortality (13.7%; reference category), which increased progressively in cluster 2 (cardiometabolic phenotype; mortality: 15.7%; adjusted HR, 1.28; 95%CI, 1.06-1.54), cluster 3 (very elderly female phenotype; mortality: 20.4%; adjusted HR, 1.63; 95%CI, 1.40-1.90), and cluster 1 (male phenotype with cardiomyopathy; mortality: 24.0%; adjusted HR, 1.81; 95%CI, 1.53-2.13). The results were very similar when each registry was analyzed individually. Treatment with renin-angiotensin system inhibitors was associated with better survival in all clusters, beta-blockers were beneficial in cluster 1, and anticoagulants in cluster 4. However, none of the treatments show ed a differential association with prognosis according to phenotype. CONCLUSIONS: This study defines 4 HFpEF phenotypes with significantly different prognoses. Among the treatments analyzed, only renin-angiotensin system inhibitors seemed to have a generalized survival benefit, and none demonstrated a differential effect based on phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeRegistriesHumansFemaleMaleSpainPhenotypeAgedSurvival RateMiddle AgedPrognosisAged, 80 and overRetrospective Studies

Stichwörter der Autor:innen

Heart failureHeart failure with preserved ejection fractionInsuficiencia cardiacaInsuficiencia cardiaca con fracción de eyección conservadaMortalidadMortalityTratamientoTreatment

Autor:innen und Institutionen

  • Servicio de Urgencias, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, Spain.
  • Servicio de Urgencias, Hôpital Saint-Louis, Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Servicio de Medicina Interna, Hospital d'Olot i Comarcal de la Garrotxa, Olot, Girona, Spain; Grupo de Investigación en Reparación y Regeneración Tisular (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida…
  • Servicio de Urgencias, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Servicio de Cardiología, Hospital Clínico de Valencia, Instituto de Investigación Sanitaria del Hospital Clínico de Valencia (INCLIVA), Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red…
  • Servicio de Cardiología, Cardiovascular Research Institute Basel, Basel, Switzerland.

Förderung

  • Novartis

Zitieren

APA

Miró, Ò., Peyrony, O., Trullàs, J. C., Alquézar-Arbé, A., Núñez, J., López-Ayala, P., Jacob, J., Bueno, H., Montero-Pérez-Barquero, M., Arévalo-Lorido, J. C., de la Espriella, R., Miñana, G., Sanchis, J., & Llorens, P. (2025). Identification of phenotypes in heart failure with preserved ejection fraction among 8161 patients from 3 Spanish cohorts. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2025.02.021

Vancouver

Miró Ò, Peyrony O, Trullàs JC, Alquézar-Arbé A, Núñez J, López-Ayala P, et al. Identification of phenotypes in heart failure with preserved ejection fraction among 8161 patients from 3 Spanish cohorts. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2025.02.021

BibTeX
@article{Mir2025,
  author = {Miró, Òscar and Peyrony, Olivier and Trullàs, Joan Carles and Alquézar-Arbé, Aitor and Núñez, Julio and López-Ayala, Pedro and Jacob, Javier and Bueno, Héctor and Montero-Pérez-Barquero, Manuel and Arévalo-Lorido, José Carlos and de la Espriella, Rafael and Miñana, Gema and Sanchis, Juan and Llorens, Pere},
  title = {Identification of phenotypes in heart failure with preserved ejection fraction among 8161 patients from 3 Spanish cohorts},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rec.2025.02.021}
}
Kostenlos starten →